Brief: Biosynex Announces Voluntary Public Tender Offer On Theradiag's Shares

Theradiag SA

23/09/2022 12:08

Sept 23 (Reuters) - Biosynex SA  ALBIO.PA :
    * FILING OF A VOLUNTARY PUBLIC TENDER OFFER FOR SHARES OF
THERADIAG
    * OBJECTIVE: TO CREATE A FRENCH CHAMPION IN MONITORING OF
BIOTHERAPIES
    * OFFER REPRESENTS A TOTAL CASH CONSIDERATION FOR THERADIAG
SHARES
OF APPROXIMATELY EUR 22.4 MILLION
    * PROPOSED TAKEOVER BID FOR THERADIAG AT PRICE OF €2.30 PER
SHARE,
REPRESENTING PREMIUM OF 58.62% OVER LAST QUOTED PRICE ON
SEPTEMBER 22, 2022 AND 43.79% OVER VOLUME-WEIGHTED AVERAGE PRICE
OVER LAST 60 DAYS PRIOR TO FILING OF TAKEOVER BID
    * BIOSYNEX DOES NOT INTEND TO REQUEST THE IMPLEMENTATION OF
A
SQUEEZE-OUT PROCEDURE AT THE END OF THIS OFFER
    * SOCIAL AND ECONOMIC COMMITTEE OF BIOSYNEX WILL MEET ON 26
SEPTEMBER 2022 TO BE INFORMED OF THE CONTENT OF THE PROPOSED
OFFER AND ITS CONSEQUENCES IN TERMS OF EMPLOYMENT

Source text for Eikon:  ID:nEQ2fC5lga 
Further company coverage:  ALBIO.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))